rs141629958

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004409.5(DMPK):​c.882+8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00491 in 1,613,900 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 40 hom. )

Consequence

DMPK
NM_004409.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00001120
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.28

Publications

2 publications found
Variant links:
Genes affected
DMPK (HGNC:2933): (DM1 protein kinase) The protein encoded by this gene is a serine-threonine kinase that is closely related to other kinases that interact with members of the Rho family of small GTPases. Substrates for this enzyme include myogenin, the beta-subunit of the L-type calcium channels, and phospholemman. The 3' untranslated region of this gene contains 5-38 copies of a CTG trinucleotide repeat. Expansion of this unstable motif to 50-5,000 copies causes myotonic dystrophy type I, which increases in severity with increasing repeat element copy number. Repeat expansion is associated with condensation of local chromatin structure that disrupts the expression of genes in this region. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2016]
DMPK Gene-Disease associations (from GenCC):
  • myotonic dystrophy type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 19-45777659-G-A is Benign according to our data. Variant chr19-45777659-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 445722.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00503 (7346/1461538) while in subpopulation MID AF = 0.0186 (107/5768). AF 95% confidence interval is 0.0175. There are 40 homozygotes in GnomAdExome4. There are 3973 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 584 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMPKNM_004409.5 linkc.882+8C>T splice_region_variant, intron_variant Intron 7 of 14 ENST00000291270.9 NP_004400.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMPKENST00000291270.9 linkc.882+8C>T splice_region_variant, intron_variant Intron 7 of 14 5 NM_004409.5 ENSP00000291270.4

Frequencies

GnomAD3 genomes
AF:
0.00382
AC:
582
AN:
152244
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00811
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0141
Gnomad FIN
AF:
0.000564
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00429
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00564
AC:
1416
AN:
251006
AF XY:
0.00645
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00654
Gnomad ASJ exome
AF:
0.00487
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000925
Gnomad NFE exome
AF:
0.00438
Gnomad OTH exome
AF:
0.00702
GnomAD4 exome
AF:
0.00503
AC:
7346
AN:
1461538
Hom.:
40
Cov.:
31
AF XY:
0.00546
AC XY:
3973
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.00116
AC:
39
AN:
33480
American (AMR)
AF:
0.00684
AC:
306
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00482
AC:
126
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0182
AC:
1572
AN:
86258
European-Finnish (FIN)
AF:
0.000941
AC:
50
AN:
53120
Middle Eastern (MID)
AF:
0.0186
AC:
107
AN:
5768
European-Non Finnish (NFE)
AF:
0.00433
AC:
4819
AN:
1111986
Other (OTH)
AF:
0.00540
AC:
326
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
459
918
1376
1835
2294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00383
AC:
584
AN:
152362
Hom.:
1
Cov.:
32
AF XY:
0.00384
AC XY:
286
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41586
American (AMR)
AF:
0.00810
AC:
124
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0147
AC:
71
AN:
4834
European-Finnish (FIN)
AF:
0.000564
AC:
6
AN:
10632
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00429
AC:
292
AN:
68022
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
30
60
90
120
150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00392
Hom.:
1
Bravo
AF:
0.00397
Asia WGS
AF:
0.00664
AC:
24
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 25, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.12
DANN
Benign
0.59
PhyloP100
-1.3
PromoterAI
0.034
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000011
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141629958; hg19: chr19-46280917; COSMIC: COSV99353892; COSMIC: COSV99353892; API